Cytonus Therapeutics, Inc

Cytonus Therapeutics, Inc., based in Columbus, OH, is at the forefront of integrating artificial intelligence with synthetic biology to revolutionize drug development. The company aims to enhance the efficacy and safety of therapeutics through its innovative Cargocyte platform, which enables targeted drug delivery to specific tissues and organs, minimizing systemic toxicity.

By leveraging proprietary AI tools, Cytonus accelerates the screening and testing of new therapeutics, addressing the high failure rates associated with traditional drug development. Their unique enucleated synthetic cells, known as Cargocytes, are designed to deliver biologic drugs directly at the site of disease, ensuring localized treatment and improved patient outcomes.

Generated from the website